Dirk Schrader has extensive work experience in the pharmaceutical industry. Dirk co-founded Goodly Innovations GmbH in 2016 and served as the CEO. From 2019, they joined AMW GmbH as an Advisory Board Member and Non-Executive Director. In 2020, they became the Global Head of Contract Manufacturing Business at Insud Pharma. Prior to that, they held the position of Executive Vice President and Head of Global Technical Operations at Vifor Pharma from 2012 to 2020. Dirk also worked at AstraZeneca, Bristol-Myers Squibb, and Bayer HealthCare in various leadership roles. Schrader has expertise in areas such as supply chain management, technical operations, and global quality management.
Dirk Schrader's education history includes attending the University of Münster, Freie Universität Berlin, Ratsgymnasium Peine, and Technische Universität Braunschweig. However, specific details regarding the degree obtained or the field of study are not provided.
In addition to their academic education, Dirk Schrader has also obtained the FT Non-Executive Director Diploma - Pearson SRF BTEC Level 7 Advanced Professional Diploma from the FT Board Director Programme in March 2022.
September, 2019 - present